Trelagliptin is a long-acting DPP-4 inhibitor that can prolong the existence of insulin in the human body, but its hypoglycemic effect is similar to that of short-acting DPP-4 inhibitors, and cannot completely replace other oral hypoglycemic drugs, let alone insulin, the main advantage of Trelagliptin is that it is easy to take.
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: